Ventilator-associated pneumonia (VAP) is one of the leading complications contributing to ICU mortality. Pulmonary infection treatment and prevention of hospital acquired infections are top of mind for caregivers and Hill-Rom.
The new Hill-Rom Clear Lungs Programme enables measurable and sustainable reductions in pulmonary complications by:
- Enabling evidence-based continuous improvement of your pulmonary therapies, protocols and their adoption
- Automating VAP bundle protocols to ensure a raised head-of-bed angle and mobilization therapies, providing peace of mind for your patients and caregivers
- Better connecting the patient to the caregiver network
A comprehensive approach to preventing and treating pulmonary complications
We understand that reducing respiratory infections and prevention of ventilator-associated pneumonia in the ICU is difficult. It takes everyone in the care continuum to work together to administer proven therapies leveraging the right tools and technologies. Only Hill-Rom takes a comprehensive approach that includes:
- Actionable analytics to evaluate protocols and measure their adherence and effectiveness
- Clinical pulmonary experts and implementation teams that work side by side with you to establish the right treatments, therapies and protocols
- Broad portfolio of intelligent beds and surfaces that provide a full range of patient mobilization capabilities that are proven to reduce hospital LOS and facility-acquired pneumonia
- Centralized monitoring and proactive alerting of unsafe conditions, such as head-of-bed angle, directly to the caregiver- wherever they are.
- Almost 14,000 respiratory products, including over 6,000 ventilators available for rent 24 hours a day, 7 days a week.